scorecardresearch
Add as a preferred source on Google
Friday, December 19, 2025
TopicBharat Biotech

Topic: Bharat Biotech

Expert panel of India’s drug regulator recommends approval for Bharat Biotech’s Covaxin

The Subject Expert Committee on Covid-19 of the Central Drugs Standard Control Organisation on Saturday deliberated on the emergency use authorisation application of Bharat Biotech.

Covid protection with placebo too? Bharat Biotech’s pitch for volunteers raises concerns

Bharat Biotech has asked Covaxin trial sites to offer Covid protection as an incentive to draw volunteers. Experts say it is unethical.

Bharat Biotech ‘thousands of volunteers short’ for ongoing Covaxin Phase 3 trials

Trial sites conducting Covaxin study say the company has given them an indicative deadline of 31 December to complete the recruitment of volunteers, but company denies claim.

Covaxin Phase 2 trials find Covid vaccine safe, no serious adverse events reported

Researchers, however, said evaluation of safety outcomes required extensive phase 3 clinical trials of the Covid vaccine developed through partnership between ICMR & Bharat Biotech.

Govt looks into new vaccine data after Pfizer, Bharat Biotech, SII seek emergency use approval

Govt had sought additional data on the vaccine candidates of companies seeking emergency use authorisation. So far, just one company has submitted this information.

‘How do we get there?’ – Bharat Biotech readies for uphill task of Covid vaccine roll out

Bharat Biotech has already produced about 10 million doses of Covaxin shot, ahead of anticipated roll out next year. But task of supplying it seems daunting.

Covaxin Phase I trial results show vaccine is safe, generates immune response

In a preprint paper, researchers from Bharat Biotech, ICMR, AIIMS have reported the results of the trial on 375 participants. 

Expert panel seeks additional data on Covid vaccines from Serum Institute, Bharat Biotech

The applications of Bharat Biotech and Serum Institute of India are under consideration, while that of the Indian arm of Pfizer has not yet been taken up.

Over 60 foreign envoys visit Bharat Biotech, Biological E to see Covid vaccine progress

The Ambassadors and High Commissioners visited the facilities of the major pharma companies, which are involved in the manufacturing of Covid vaccine candidate, Covaxin.

Approval, pricing, distribution — 5 questions India faces before rolling out Covid vaccine

3 firms have applied for emergency use approval, but no clarity yet on if people will get to choose a vaccine, or what the state’s role in procurement will be.

On Camera

Bondi attack shows marginalisation isn’t driving ISIS. Extremism must be stopped from within

Without falling into a cycle of hatred, we can name what we are confronting — the ideological framework of ISIS for which the world is divided into believers and non-believers.

Antitrust watchdog Competition Commission to probe IndiGo flight disruptions

While the commission didn’t mention provisions under which IndiGo's market domination would be examined, Competition Act 2002 prohibits abuse of dominant position by any enterprise.

Israel has ‘realised who its real friend is’, eyes defence expansion in India amid arms curbs by others

It is argued that India-Israel ties are moving from buyer–seller dynamic to one focused on joint development & manufacturing partnership, a shift 'more durable' than traditional arms sales.

India’s top airline just handed sarkar the keys. That’s IndiGo’s real ‘crime’

Don’t blame misfortune. This is colossal incompetence and insensitivity. So bad, heads would have rolled even in the old PSU-era Indian Airlines and Air India.